Arizona Centers Team on Heart, Vascular Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Arizona Heart Institute and Arizona Research Center will partner on cardiovascular research that will include genomics, epigenetics, and large, multi-center drug and medical device trials, AHI said today.

The collaboration, focused on heart and vascular diseases, will give AZRC access to patients that may qualify for pharmaceutical and device research studies, and will enable AHI to pursue epigenetic and genomic studies in efforts to develop early-stage diagnostics that could allow for interventions before symptoms present.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.